Moreover, there are numerous evidence of disrupted functional connectivity (FC) of DMN in AD patients[5,6] and related risk populations, such as amnestic mild cognitive impairment (aMCI) patients[7,8]and APOE ε4 carriers[9–12]. Here, APOE is linked to Alzheimer disease.